FDA Adverse Event Injury Summary report: N

ACRYSOF IQ NATURAL SINGLEPIECE IOL

MDR report key: 4995206 · Received August 12, 2015

Report

Report Number
9612169-2015-00572
Event Type
Injury
Date Received
August 12, 2015
Date of Event
September 27, 2000
Report Date
November 4, 2015
Manufacturer
ALCON LABORATORIES IRELAND LTD.
Product Code
HQL
PMA / PMN Number
P930014
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

EVALUATION SUMMARY: RESULTS FROM THE PRODUCT HISTORY RECORD AND BATCH HISTORY RECORD REVIEW INDICATED THE PRODUCT MET RELEASE CRITERIA. THE LENS WAS RETURNED IN A SPECIMEN CONTAINER FILLED WITH A CLEAR UNKNOWN LIQUID. ONE HAPTIC WAS BROKEN/TORN AND NOT RETURNED. THE OPTIC WAS TORN/SPLIT/CRACKED AND SCRATCHED/MARKED-REJECTABLE. THE OPTIC HAD ADDITIONAL DAMAGE THAT GAVE THE APPEARANCE OF BLACKISH MICRO-CRACKS. NO OPACIFICATION WAS OBSERVED ON THE LENS; HOWEVER, DURING INVESTIGATION OF THE RETURNED SAMPLE, DAMAGE (BLACKISH MICRO-CRACKS) WAS OBSERVED TO THE OPTIC WHICH MAY HAVE BEEN INTERPRETED AS THE REPORTED COMPLAINT. THIS TYPE OF DAMAGE HAS BEEN SEEN IN THE PAST AND IS TYPICAL OF THE DAMAGE CAUSED BY YAG LASER CONDUCTED POST IMPLANTATION. WHILE IT IS UNABLE TO DETERMINE THE ORIGIN OF THIS DAMAGE, IT CAN BE CONCLUDED THAT IT WAS NOT PROBABLY MANUFACTURING RELATED. BASED ON THESE INVESTIGATION FINDINGS, IT IS UNABLE TO VERIFY IF THE LENS CONTRIBUTED TO THE EVENT.

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

A SAMPLE IS IN TRANSIT TO THE MANUFACTURING SITE FOR INVESTIGATION. INVESTIGATION INCLUDING ROOT CAUSE ANALYSIS IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 1

A DOCTOR OF OPHTHALMOLOGY REPORTED THAT AFTER AN INTRAOCULAR LENS (IOL) IMPLANT SURGERY THE PATIENT EXPERIENCED A LENS OPACIFICATION. THE IOL WAS EXPLANTED AND AN IRIDECTOMY AND VITRECTOMY WERE PERFORMED. ADDITIONAL INFORMATION HAS BEEN REQUESTED WITH NO RESPONSE TO DATE. THIS IS ONE OF TWO REPORTS BEING FILED FOR THIS PATIENT. THIS REPORT IS FOR PATIENT'S RIGHT EYE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
531849 ACRYSOF IQ NATURAL SINGLEPIECE IOL INTRAOCULAR LENS HQL ALCON LABORATORIES IRELAND LTD. SN60WF 21000604

Patients

Seq Age Sex Outcome Treatment
1 35 YR Other| R VISCOAT